Intermediate filament proteins are reliable immunohistological biomarkers to help diagnose multiple tissue-specific diseases

• Published in: Anatomia, histologia, embryologia histologia, embryologia, 2023-09, Vol.52 (5), p.655-672
• Main Authors: Doganyigit, Zuleyha, Eroglu, Ece, Okan, Aslı
• Format: Article
• Language: English
• Subjects: Actin; Cataracts; Cell differentiation; Cirrhosis; Colorectal carcinoma; Cytoskeleton; Desmin; Filaments; Glial fibrillary acidic protein; Hepatitis; Immunoreactivity; Intermediate filaments; Lamins; Mechanical stimuli; Microtubules; Pancreatitis; Proteins; Urothelial carcinoma; Vimentin
• ISSN: 0340-2096; 1439-0264
• DOI: 10.1111/ahe.12937

Cytoskeletal networks are proteins that effectively maintain cell integrity and provide mechanical support to cells by actively transmitting mechanical signals. Intermediate filaments, which are from the cytoskeleton family and are 10 nanometres in diameter, are unlike actin and microtubules, which are highly dynamic cytoskeletal elements. Intermediate filaments are flexible at low strain, harden at high strain and resist breaking. For this reason, these filaments fulfil structural functions by providing mechanical support to the cells through their different strain-hardening properties. Intermediate filaments are suitable in that cells both cope with mechanical forces and modulate signal transmission. These filaments are composed of fibrous proteins that exhibit a central α-helical rod domain with a conserved substructure. Intermediate filament proteins are divided into six groups. Type I and type II include acidic and basic keratins, type III, vimentin, desmin, peripheralin and glial fibrillary acidic protein (GFAP), respectively. Type IV intermediate filament group includes neurofilament proteins and a fourth neurofilament subunit, α-internexin proteins. Type V consists of lamins located in the nucleus, and the type VI group consists of lens-specific intermediate filaments, CP49/phakinin and filen. Intermediate filament proteins show specific immunoreactivity in differentiating cells and mature cells of various types. Various carcinomas such as colorectal, urothelial and ovarian, diseases such as chronic pancreatitis, cirrhosis, hepatitis and cataract have been associated with intermediate filaments. Accordingly, this section reviews available immunohistochemical antibodies to intermediate filament proteins. Identification of intermediate filament proteins by methodological methods may contribute to the understanding of complex diseases.